WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

A COMPARATIVE STUDY OF VIDANGADI VATI AND BHARANGYADI VATI IN THE MANAGEMENT OF TAMAK SHWASA W.S.R TO BRONCHIAL ASTHMA.

Dr. Shital Bhagiya*, Dr. Ankita Limbachiya, Dr. Shrija Mavani and Dr. Nirav Unadakat

ABSTRACT

Background: As prevalence of Asthma is increasing steadily over the lateral part of the last century, first in the developed and developing world. Today’s life is running so fast that people can’t follow Dincharaya and Ritucharya which has been described in our texts and therefore, patients with chronic airway disorders like Shwasa are increasing. Acharya Charaka mentioned Shwasa as Ashivisha like, Pranhara and Paramdurjaya Vyadhi, Therefore its early management has been stressed so that patient may not be distressed by chronicity of Shwasa. Therefor the study was aimed to study etiopathogenesis, symptomatology and epidemiology of the Tamakshwasa and to assess efficacy of Vidangadi vati and Bharangyadi vati in the management of Tamakshwasa. Method: Thirty patients suffering from Tamakshwasa (Bronchial Asthma) between the age group of 16 to 60 years of either sex participated in the study. Study was a randomized, controlled, open label clinical study. Patients were randomly divided into two groups: Group A (n = 15) received Vidangadivati, 4 tab-tds (500mg for 1 tab.) for 6 weeks with Ushnajala. Group B (n = 15) Bharangyadivati with same dose and duration. Assessments were done after six weeks in both groups. Result: In Group A moderate response was found in 53.33% of cases, mild improvement in 26.66% of cases and 20% of patients had no relief. In Group B moderate response was found in 60% of cases, mild improvement in 26.66% of cases and 13.33% of patients had no relief. Conclusion: Study showed that Vidangadi vati is more effective in Tamakshwas then Bharngyadi vati.

Keywords: Bharangyadi Vati, Bronchial Asthma, Tamakshwasa, Vidangadi Vati.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More